Rank | Gene Set | Z-score |
---|---|---|
1 | fusion of sperm to egg plasma membrane (GO:0007342) | 5.28374919 |
2 | regulation of cholesterol esterification (GO:0010872) | 5.12915069 |
3 | mitochondrial calcium ion transport (GO:0006851) | 4.60946065 |
4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.32165651 |
5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.32165651 |
6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.32165651 |
7 | modulation by symbiont of host immune response (GO:0052553) | 4.32165651 |
8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.32165651 |
9 | modulation by symbiont of host defense response (GO:0052031) | 4.32165651 |
10 | glycosphingolipid catabolic process (GO:0046479) | 4.31883717 |
11 | adenosine receptor signaling pathway (GO:0001973) | 4.15453155 |
12 | response to peptidoglycan (GO:0032494) | 4.12804893 |
13 | amino sugar catabolic process (GO:0046348) | 3.95192942 |
14 | NIK/NF-kappaB signaling (GO:0038061) | 3.93399421 |
15 | glycolipid catabolic process (GO:0019377) | 3.89190800 |
16 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.87275956 |
17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.86886589 |
18 | plasma membrane fusion (GO:0045026) | 3.83491165 |
19 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.75392238 |
20 | neutrophil activation involved in immune response (GO:0002283) | 3.71922547 |
21 | sperm motility (GO:0030317) | 3.71044433 |
22 | macrophage activation involved in immune response (GO:0002281) | 3.69490202 |
23 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.69363088 |
24 | negative regulation of cell size (GO:0045792) | 3.58219854 |
25 | regulation of mast cell degranulation (GO:0043304) | 3.57834154 |
26 | acrosome reaction (GO:0007340) | 3.52618831 |
27 | positive regulation of mast cell degranulation (GO:0043306) | 3.49280144 |
28 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.49280144 |
29 | mannose metabolic process (GO:0006013) | 3.46973651 |
30 | hyaluronan catabolic process (GO:0030214) | 3.46552779 |
31 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.44426588 |
32 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.43671432 |
33 | barbed-end actin filament capping (GO:0051016) | 3.40004304 |
34 | ceramide catabolic process (GO:0046514) | 3.36930026 |
35 | sulfur amino acid catabolic process (GO:0000098) | 3.34434764 |
36 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.33047669 |
37 | cellular response to arsenic-containing substance (GO:0071243) | 3.32492124 |
38 | pinocytosis (GO:0006907) | 3.28821780 |
39 | lipoxygenase pathway (GO:0019372) | 3.25337399 |
40 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.19384357 |
41 | response to host immune response (GO:0052572) | 3.19384357 |
42 | oligosaccharide catabolic process (GO:0009313) | 3.18300947 |
43 | regulation of leukocyte degranulation (GO:0043300) | 3.16185582 |
44 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.15278753 |
45 | sperm capacitation (GO:0048240) | 3.14855292 |
46 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.14746300 |
47 | COPI coating of Golgi vesicle (GO:0048205) | 3.14190883 |
48 | Golgi transport vesicle coating (GO:0048200) | 3.14190883 |
49 | microglial cell activation (GO:0001774) | 3.13813621 |
50 | I-kappaB phosphorylation (GO:0007252) | 3.13430813 |
51 | regulation of early endosome to late endosome transport (GO:2000641) | 3.12078152 |
52 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.08355364 |
53 | negative regulation of digestive system process (GO:0060457) | 3.08123120 |
54 | response to acidic pH (GO:0010447) | 3.05921561 |
55 | alpha-linolenic acid metabolic process (GO:0036109) | 3.05303216 |
56 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.04001061 |
57 | membrane protein intracellular domain proteolysis (GO:0031293) | 3.03941413 |
58 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.02110981 |
59 | negative regulation of interleukin-12 production (GO:0032695) | 3.01606430 |
60 | peptide catabolic process (GO:0043171) | 3.01142558 |
61 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.00752672 |
62 | response to host (GO:0075136) | 3.00752672 |
63 | response to host defenses (GO:0052200) | 3.00752672 |
64 | neutrophil mediated immunity (GO:0002446) | 3.00412716 |
65 | valine metabolic process (GO:0006573) | 3.00038098 |
66 | sequestering of metal ion (GO:0051238) | 2.99952733 |
67 | low-density lipoprotein particle clearance (GO:0034383) | 2.99166239 |
68 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.98050016 |
69 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.97130368 |
70 | protein carboxylation (GO:0018214) | 2.97130368 |
71 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.97075633 |
72 | membrane lipid catabolic process (GO:0046466) | 2.94752547 |
73 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.94040695 |
74 | L-phenylalanine catabolic process (GO:0006559) | 2.94040695 |
75 | polyamine biosynthetic process (GO:0006596) | 2.92924182 |
76 | sphingolipid catabolic process (GO:0030149) | 2.92653182 |
77 | protein localization to endosome (GO:0036010) | 2.92311377 |
78 | detection of molecule of bacterial origin (GO:0032490) | 2.91233851 |
79 | response to thyroid hormone (GO:0097066) | 2.90955187 |
80 | low-density lipoprotein particle remodeling (GO:0034374) | 2.87900635 |
81 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.87866764 |
82 | cellular modified amino acid catabolic process (GO:0042219) | 2.85742636 |
83 | reverse cholesterol transport (GO:0043691) | 2.85207522 |
84 | keratan sulfate catabolic process (GO:0042340) | 2.82765301 |
85 | immunoglobulin mediated immune response (GO:0016064) | 2.82253304 |
86 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.81984407 |
87 | regulation of cholesterol efflux (GO:0010874) | 2.81523413 |
88 | tooth mineralization (GO:0034505) | 2.81374206 |
89 | regulation of mast cell activation (GO:0033003) | 2.80452785 |
90 | protein retention in ER lumen (GO:0006621) | 2.80248003 |
91 | multicellular organism reproduction (GO:0032504) | 2.76929661 |
92 | plasma lipoprotein particle clearance (GO:0034381) | 2.76473813 |
93 | regulation of chemokine biosynthetic process (GO:0045073) | 2.75705834 |
94 | cellular extravasation (GO:0045123) | 2.73932778 |
95 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.73257088 |
96 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.73257088 |
97 | cellular response to ATP (GO:0071318) | 2.73234714 |
98 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.72954663 |
99 | high-density lipoprotein particle remodeling (GO:0034375) | 2.72905690 |
100 | regulation of cholesterol storage (GO:0010885) | 2.72326399 |
101 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.72018462 |
102 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.69206665 |
103 | positive regulation of receptor recycling (GO:0001921) | 2.68076937 |
104 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.67595750 |
105 | plasma lipoprotein particle organization (GO:0071827) | 2.67350653 |
106 | plasma lipoprotein particle assembly (GO:0034377) | 2.66666010 |
107 | apoptotic cell clearance (GO:0043277) | 2.66663254 |
108 | protein-lipid complex remodeling (GO:0034368) | 2.65101285 |
109 | macromolecular complex remodeling (GO:0034367) | 2.65101285 |
110 | plasma lipoprotein particle remodeling (GO:0034369) | 2.65101285 |
111 | macrophage activation (GO:0042116) | 2.64737702 |
112 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.64722823 |
113 | branching involved in prostate gland morphogenesis (GO:0060442) | 2.63521753 |
114 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.62329575 |
115 | protein-lipid complex subunit organization (GO:0071825) | 2.61162102 |
116 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.61157656 |
117 | decidualization (GO:0046697) | 2.60295114 |
118 | membrane protein ectodomain proteolysis (GO:0006509) | 2.59785548 |
119 | cysteine metabolic process (GO:0006534) | 2.59537167 |
120 | chromosome condensation (GO:0030261) | 2.57704036 |
121 | myelin assembly (GO:0032288) | 2.56991384 |
122 | regulation of mononuclear cell migration (GO:0071675) | 2.56949287 |
123 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.56866266 |
124 | exocrine pancreas development (GO:0031017) | 2.56277429 |
125 | L-phenylalanine metabolic process (GO:0006558) | 2.56103560 |
126 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.56103560 |
127 | protein-lipid complex assembly (GO:0065005) | 2.56084022 |
128 | transcytosis (GO:0045056) | 2.55902380 |
129 | aldehyde catabolic process (GO:0046185) | 2.53813720 |
130 | detection of other organism (GO:0098543) | 2.53708340 |
131 | detection of external biotic stimulus (GO:0098581) | 2.53137205 |
132 | reproduction (GO:0000003) | 2.52984546 |
133 | respiratory burst (GO:0045730) | 2.51360132 |
134 | phospholipid efflux (GO:0033700) | 2.51314749 |
135 | positive regulation of leukocyte degranulation (GO:0043302) | 2.50813096 |
136 | aromatic amino acid family catabolic process (GO:0009074) | 2.49585278 |
137 | adhesion of symbiont to host cell (GO:0044650) | 2.49234930 |
138 | virion attachment to host cell (GO:0019062) | 2.49234930 |
139 | positive regulation of calcium ion import (GO:0090280) | 2.48510211 |
140 | complement activation, alternative pathway (GO:0006957) | 2.48001141 |
141 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.47646375 |
142 | positive regulation of interferon-alpha production (GO:0032727) | 2.47273121 |
143 | regulation of heat generation (GO:0031650) | 2.47040875 |
144 | cholesterol efflux (GO:0033344) | 2.46740575 |
145 | positive regulation of B cell differentiation (GO:0045579) | 2.45725059 |
146 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.44499474 |
147 | rRNA methylation (GO:0031167) | 2.43902949 |
148 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.43217127 |
149 | stress fiber assembly (GO:0043149) | 2.42531101 |
150 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.42149836 |
151 | N-acetylneuraminate metabolic process (GO:0006054) | 2.41358473 |
152 | adhesion of symbiont to host (GO:0044406) | 2.41257284 |
153 | phospholipid homeostasis (GO:0055091) | 2.41158657 |
154 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.41003104 |
155 | sexual reproduction (GO:0019953) | 2.40061985 |
156 | regulation of protein activation cascade (GO:2000257) | 2.39680112 |
157 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.39032778 |
158 | positive regulation of mast cell activation (GO:0033005) | 2.38553975 |
159 | DNA packaging (GO:0006323) | 2.38183497 |
160 | positive regulation of interleukin-6 production (GO:0032755) | 2.37943796 |
161 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.37280581 |
162 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.37239040 |
163 | single strand break repair (GO:0000012) | 2.36680489 |
164 | regulation of complement activation (GO:0030449) | 2.36235324 |
165 | negative regulation of necrotic cell death (GO:0060547) | 2.35842391 |
166 | amyloid precursor protein catabolic process (GO:0042987) | 2.34994617 |
167 | positive regulation of type 2 immune response (GO:0002830) | 2.34403184 |
168 | myeloid dendritic cell differentiation (GO:0043011) | 2.33758402 |
169 | granulocyte activation (GO:0036230) | 2.33639148 |
170 | regulation of podosome assembly (GO:0071801) | 2.32973668 |
171 | regulation of type 2 immune response (GO:0002828) | 2.32555016 |
172 | lytic vacuole organization (GO:0080171) | 2.32496000 |
173 | lysosome organization (GO:0007040) | 2.32496000 |
174 | myeloid leukocyte mediated immunity (GO:0002444) | 2.31579273 |
175 | tryptophan metabolic process (GO:0006568) | 2.31544929 |
176 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.31373565 |
177 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.31293161 |
178 | negative regulation of mast cell activation (GO:0033004) | 2.30939189 |
179 | negative regulation of cholesterol transport (GO:0032375) | 2.29502133 |
180 | negative regulation of sterol transport (GO:0032372) | 2.29502133 |
181 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.29327808 |
182 | hormone catabolic process (GO:0042447) | 2.28558399 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.50942137 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.30146055 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.67641029 |
4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.59911040 |
5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.52524289 |
6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.38178504 |
7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.22741575 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.98045506 |
9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.80772266 |
10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.79172640 |
11 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.79109413 |
12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.53820703 |
13 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.51697456 |
14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.51686994 |
15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.50606848 |
16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.45440194 |
17 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.42143283 |
18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.37253340 |
19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.35570642 |
20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.29691875 |
21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.26707423 |
22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.17137301 |
23 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.13899475 |
24 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 2.12208171 |
25 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.10469242 |
26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.06834676 |
27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.04594098 |
28 | * P68_20966046_ChIP-Seq_HELA_Human | 2.00417905 |
29 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.99845893 |
30 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.99553207 |
31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.93829503 |
32 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.93091555 |
33 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.84858904 |
34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.80052927 |
35 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73462306 |
36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.67629353 |
37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.66305177 |
38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.66121619 |
39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.66058365 |
40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.64926215 |
41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.63018914 |
42 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.62860339 |
43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.61596231 |
44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58068635 |
45 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.57475586 |
46 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.57462466 |
47 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.56700916 |
48 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.56434318 |
49 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.54958565 |
50 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.53798846 |
51 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.53671836 |
52 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.53526698 |
53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.53196407 |
54 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.53012344 |
55 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.53012344 |
56 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.50280610 |
57 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.49437813 |
58 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.48731260 |
59 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.48561804 |
60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.44779621 |
61 | MAF_26560356_Chip-Seq_TH2_Human | 1.43296805 |
62 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.42932708 |
63 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42148230 |
64 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.41485114 |
65 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.40741350 |
66 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.37805171 |
67 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.36983676 |
68 | MAF_26560356_Chip-Seq_TH1_Human | 1.35642612 |
69 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35278800 |
70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.34955768 |
71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34736385 |
72 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34549018 |
73 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.34430430 |
74 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32796984 |
75 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.32767209 |
76 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.31908131 |
77 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.30232328 |
78 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.29838023 |
79 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.28680328 |
80 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.26915940 |
81 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.25830142 |
82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24909235 |
83 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.24364979 |
84 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22491390 |
85 | KDM2B_26808549_Chip-Seq_K562_Human | 1.21508211 |
86 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.21296266 |
87 | UTX_26944678_Chip-Seq_JUKART_Human | 1.20676607 |
88 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.20109345 |
89 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.19528792 |
90 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.19339351 |
91 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.19148601 |
92 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.18775248 |
93 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18259842 |
94 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17724520 |
95 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.17507634 |
96 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.17025381 |
97 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16766344 |
98 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15890940 |
99 | GATA2_19941826_ChIP-Seq_K562_Human | 1.15683756 |
100 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.15407567 |
101 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14992796 |
102 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14479020 |
103 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.14366258 |
104 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13361414 |
105 | SA1_27219007_Chip-Seq_Bcells_Human | 1.12344586 |
106 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.11932319 |
107 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.11787978 |
108 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.11494662 |
109 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11306146 |
110 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.10976548 |
111 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.10621409 |
112 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.10475233 |
113 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.10335610 |
114 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.10132398 |
115 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09717301 |
116 | P300_27268052_Chip-Seq_Bcells_Human | 1.09551038 |
117 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09102509 |
118 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08611491 |
119 | CJUN_26792858_Chip-Seq_BT549_Human | 1.08074960 |
120 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07965182 |
121 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07348432 |
122 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.07204123 |
123 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.07169139 |
124 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06728277 |
125 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.05697265 |
126 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.05619332 |
127 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04216728 |
128 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.04212915 |
129 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04097712 |
130 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.03755142 |
131 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03484431 |
132 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02745269 |
133 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02677743 |
134 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01499239 |
135 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01445109 |
136 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00345938 |
137 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00253004 |
138 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98787930 |
139 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98632719 |
140 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.98530032 |
141 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98405314 |
142 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96173273 |
143 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95648324 |
144 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95320163 |
145 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.94591784 |
146 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.93998269 |
147 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.93980039 |
148 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93637392 |
149 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90924144 |
150 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88300670 |
151 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.88100852 |
152 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.86394582 |
153 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84590351 |
154 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.84373084 |
155 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83570532 |
156 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82332424 |
157 | SPI1_23127762_ChIP-Seq_K562_Human | 0.81178579 |
158 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.78395014 |
159 | GATA3_26560356_Chip-Seq_TH2_Human | 0.77547871 |
160 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.77177722 |
161 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.77112176 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005058_abnormal_lysosome_morphology | 4.63050033 |
2 | MP0005410_abnormal_fertilization | 3.98136949 |
3 | MP0002139_abnormal_hepatobiliary_system | 3.25219967 |
4 | MP0008438_abnormal_cutaneous_collagen | 3.13599172 |
5 | MP0005365_abnormal_bile_salt | 3.04205862 |
6 | MP0005360_urolithiasis | 3.04044906 |
7 | MP0009840_abnormal_foam_cell | 2.85465448 |
8 | MP0003300_gastrointestinal_ulcer | 2.59040475 |
9 | MP0003191_abnormal_cellular_cholesterol | 2.57618153 |
10 | MP0005451_abnormal_body_composition | 2.51497061 |
11 | MP0008004_abnormal_stomach_pH | 2.49063956 |
12 | MP0006082_CNS_inflammation | 2.44863561 |
13 | MP0000678_abnormal_parathyroid_gland | 2.44552040 |
14 | MP0003172_abnormal_lysosome_physiology | 2.41306187 |
15 | MP0003436_decreased_susceptibility_to | 2.31985163 |
16 | MP0004510_myositis | 2.21652206 |
17 | MP0003183_abnormal_peptide_metabolism | 2.19810727 |
18 | MP0005085_abnormal_gallbladder_physiolo | 2.19133941 |
19 | MP0010386_abnormal_urinary_bladder | 2.14347200 |
20 | MP0000013_abnormal_adipose_tissue | 2.05850571 |
21 | MP0003690_abnormal_glial_cell | 2.00231644 |
22 | MP0009764_decreased_sensitivity_to | 1.95347630 |
23 | MP0008260_abnormal_autophagy | 1.93358973 |
24 | MP0002419_abnormal_innate_immunity | 1.92725429 |
25 | MP0010329_abnormal_lipoprotein_level | 1.91163448 |
26 | MP0003705_abnormal_hypodermis_morpholog | 1.87063596 |
27 | * MP0005332_abnormal_amino_acid | 1.81892842 |
28 | MP0003806_abnormal_nucleotide_metabolis | 1.81770450 |
29 | MP0001666_abnormal_nutrient_absorption | 1.79318995 |
30 | MP0002877_abnormal_melanocyte_morpholog | 1.77593012 |
31 | MP0001533_abnormal_skeleton_physiology | 1.76008052 |
32 | MP0003329_amyloid_beta_deposits | 1.74415038 |
33 | MP0003252_abnormal_bile_duct | 1.69838867 |
34 | MP0005671_abnormal_response_to | 1.68369413 |
35 | MP0004019_abnormal_vitamin_homeostasis | 1.61561502 |
36 | MP0003724_increased_susceptibility_to | 1.58968525 |
37 | MP0008875_abnormal_xenobiotic_pharmacok | 1.58130354 |
38 | MP0001835_abnormal_antigen_presentation | 1.57862598 |
39 | MP0009333_abnormal_splenocyte_physiolog | 1.52024125 |
40 | MP0002254_reproductive_system_inflammat | 1.48163637 |
41 | MP0001958_emphysema | 1.46695489 |
42 | MP0003566_abnormal_cell_adhesion | 1.45872866 |
43 | MP0005464_abnormal_platelet_physiology | 1.45698240 |
44 | MP0005310_abnormal_salivary_gland | 1.44949990 |
45 | MP0003878_abnormal_ear_physiology | 1.40680561 |
46 | MP0005377_hearing/vestibular/ear_phenot | 1.40680561 |
47 | MP0001545_abnormal_hematopoietic_system | 1.40231213 |
48 | MP0005397_hematopoietic_system_phenotyp | 1.40231213 |
49 | MP0004947_skin_inflammation | 1.39622532 |
50 | MP0002148_abnormal_hypersensitivity_rea | 1.38774569 |
51 | MP0003656_abnormal_erythrocyte_physiolo | 1.36487641 |
52 | MP0004233_abnormal_muscle_weight | 1.35972334 |
53 | MP0002138_abnormal_hepatobiliary_system | 1.31442931 |
54 | MP0009643_abnormal_urine_homeostasis | 1.31273801 |
55 | MP0000015_abnormal_ear_pigmentation | 1.27245629 |
56 | MP0000604_amyloidosis | 1.25621172 |
57 | MP0002405_respiratory_system_inflammati | 1.24921100 |
58 | MP0000609_abnormal_liver_physiology | 1.24832183 |
59 | MP0010307_abnormal_tumor_latency | 1.24081941 |
60 | MP0005275_abnormal_skin_tensile | 1.23393224 |
61 | MP0002118_abnormal_lipid_homeostasis | 1.23034675 |
62 | MP0006054_spinal_hemorrhage | 1.22891507 |
63 | MP0001756_abnormal_urination | 1.22766972 |
64 | MP0009785_altered_susceptibility_to | 1.21200752 |
65 | MP0003091_abnormal_cell_migration | 1.20626298 |
66 | MP0005164_abnormal_response_to | 1.20171460 |
67 | MP0002998_abnormal_bone_remodeling | 1.19976844 |
68 | MP0001845_abnormal_inflammatory_respons | 1.18997012 |
69 | MP0000371_diluted_coat_color | 1.18496209 |
70 | MP0000343_altered_response_to | 1.17790945 |
71 | MP0004883_abnormal_blood_vessel | 1.16900486 |
72 | MP0003075_altered_response_to | 1.16111323 |
73 | MP0008469_abnormal_protein_level | 1.15333296 |
74 | MP0002132_abnormal_respiratory_system | 1.15145078 |
75 | MP0005390_skeleton_phenotype | 1.12490780 |
76 | MP0001849_ear_inflammation | 1.11081881 |
77 | MP0005025_abnormal_response_to | 1.08743963 |
78 | MP0000465_gastrointestinal_hemorrhage | 1.08609641 |
79 | MP0003453_abnormal_keratinocyte_physiol | 1.07985802 |
80 | MP0005166_decreased_susceptibility_to | 1.07472086 |
81 | MP0005023_abnormal_wound_healing | 1.07052201 |
82 | MP0005000_abnormal_immune_tolerance | 1.06592435 |
83 | MP0000858_altered_metastatic_potential | 1.05704419 |
84 | MP0005220_abnormal_exocrine_pancreas | 1.04448263 |
85 | MP0005319_abnormal_enzyme/_coenzyme | 1.03917719 |
86 | MP0004264_abnormal_extraembryonic_tissu | 1.03448763 |
87 | MP0002420_abnormal_adaptive_immunity | 1.01730004 |
88 | MP0001819_abnormal_immune_cell | 1.01611956 |
89 | MP0002452_abnormal_antigen_presenting | 1.01104157 |
90 | MP0005257_abnormal_intraocular_pressure | 1.00852836 |
91 | MP0002060_abnormal_skin_morphology | 1.00410392 |
92 | MP0003828_pulmonary_edema | 1.00351445 |
93 | MP0002136_abnormal_kidney_physiology | 1.00342183 |
94 | MP0000003_abnormal_adipose_tissue | 0.95663033 |
95 | MP0003279_aneurysm | 0.94698598 |
96 | MP0003186_abnormal_redox_activity | 0.93996307 |
97 | MP0001790_abnormal_immune_system | 0.93791172 |
98 | MP0005387_immune_system_phenotype | 0.93791172 |
99 | MP0003011_delayed_dark_adaptation | 0.93403406 |
100 | MP0002090_abnormal_vision | 0.91065323 |
101 | MP0005167_abnormal_blood-brain_barrier | 0.90930385 |
102 | MP0001243_abnormal_dermal_layer | 0.90429137 |
103 | MP0005083_abnormal_biliary_tract | 0.89832928 |
104 | MP0001800_abnormal_humoral_immune | 0.88172545 |
105 | MP0000538_abnormal_urinary_bladder | 0.86434459 |
106 | MP0005647_abnormal_sex_gland | 0.86049988 |
107 | MP0000598_abnormal_liver_morphology | 0.85797858 |
108 | MP0005503_abnormal_tendon_morphology | 0.84685588 |
109 | MP0000249_abnormal_blood_vessel | 0.83747081 |
110 | MP0009278_abnormal_bone_marrow | 0.83416809 |
111 | MP0005409_darkened_coat_color | 0.83029753 |
112 | MP0009763_increased_sensitivity_to | 0.81890163 |
113 | MP0004858_abnormal_nervous_system | 0.81672947 |
114 | MP0005670_abnormal_white_adipose | 0.80189878 |
115 | MP0005171_absent_coat_pigmentation | 0.79049527 |
116 | * MP0003795_abnormal_bone_structure | 0.79045702 |
117 | MP0000685_abnormal_immune_system | 0.78513151 |
118 | MP0002723_abnormal_immune_serum | 0.78508991 |
119 | MP0001853_heart_inflammation | 0.78303422 |
120 | MP0004043_abnormal_pH_regulation | 0.78210903 |
121 | MP0000767_abnormal_smooth_muscle | 0.77509905 |
122 | MP0002098_abnormal_vibrissa_morphology | 0.76895081 |
123 | MP0002653_abnormal_ependyma_morphology | 0.76544685 |
124 | MP0002938_white_spotting | 0.75963652 |
125 | MP0001324_abnormal_eye_pigmentation | 0.75466807 |
126 | MP0001764_abnormal_homeostasis | 0.75162766 |
127 | MP0009384_cardiac_valve_regurgitation | 0.75012507 |
128 | MP0003448_altered_tumor_morphology | 0.74859410 |
129 | MP0003303_peritoneal_inflammation | 0.73795929 |
130 | MP0003698_abnormal_male_reproductive | 0.73725184 |
131 | MP0000716_abnormal_immune_system | 0.72057478 |
132 | MP0005174_abnormal_tail_pigmentation | 0.71925727 |
133 | MP0002429_abnormal_blood_cell | 0.68974322 |
134 | MP0003950_abnormal_plasma_membrane | 0.68489561 |
135 | MP0004808_abnormal_hematopoietic_stem | 0.67063834 |
136 | MP0000920_abnormal_myelination | 0.66331943 |
137 | MP0009115_abnormal_fat_cell | 0.65310313 |
138 | MP0001348_abnormal_lacrimal_gland | 0.65115599 |
139 | MP0004381_abnormal_hair_follicle | 0.64935061 |
140 | MP0002398_abnormal_bone_marrow | 0.64335070 |
141 | MP0002127_abnormal_cardiovascular_syste | 0.64300858 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Vacuolated lymphocytes (HP:0001922) | 5.90668322 |
2 | Increased cerebral lipofuscin (HP:0011813) | 4.68318680 |
3 | Dysostosis multiplex (HP:0000943) | 4.62572284 |
4 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.46936112 |
5 | Systemic lupus erythematosus (HP:0002725) | 4.20576837 |
6 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.09031085 |
7 | Mucopolysacchariduria (HP:0008155) | 4.09031085 |
8 | Purpura (HP:0000979) | 3.96017045 |
9 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.95678865 |
10 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.95678865 |
11 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.95678865 |
12 | Petechiae (HP:0000967) | 3.88430878 |
13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.74286696 |
14 | Loss of speech (HP:0002371) | 3.70902920 |
15 | Recurrent bacterial skin infections (HP:0005406) | 3.47690474 |
16 | Eczematoid dermatitis (HP:0000976) | 3.45470615 |
17 | Recurrent abscess formation (HP:0002722) | 3.38096515 |
18 | Prolonged neonatal jaundice (HP:0006579) | 3.37241957 |
19 | Glomerulonephritis (HP:0000099) | 3.21685591 |
20 | Abnormality of glycolipid metabolism (HP:0010969) | 3.20578654 |
21 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.20578654 |
22 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.20578654 |
23 | Abnormality of macrophages (HP:0004311) | 3.15952066 |
24 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.15024563 |
25 | Axonal loss (HP:0003447) | 3.08822664 |
26 | Nuclear cataract (HP:0100018) | 3.08441686 |
27 | Complement deficiency (HP:0004431) | 3.05231703 |
28 | Severe visual impairment (HP:0001141) | 3.03649771 |
29 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.97851056 |
30 | Xanthomatosis (HP:0000991) | 2.95676799 |
31 | Intrahepatic cholestasis (HP:0001406) | 2.90184524 |
32 | Epistaxis (HP:0000421) | 2.83651436 |
33 | Prolonged bleeding time (HP:0003010) | 2.83092913 |
34 | Increased serum ferritin (HP:0003281) | 2.81291875 |
35 | Thin bony cortex (HP:0002753) | 2.81209517 |
36 | Spontaneous hematomas (HP:0007420) | 2.70731137 |
37 | * Male infertility (HP:0003251) | 2.64817061 |
38 | Progressive visual loss (HP:0000529) | 2.64307581 |
39 | Abnormality of the nasal mucosa (HP:0000433) | 2.64025257 |
40 | Hydroxyprolinuria (HP:0003080) | 2.63858377 |
41 | Abnormality of proline metabolism (HP:0010907) | 2.63858377 |
42 | Deep venous thrombosis (HP:0002625) | 2.60885310 |
43 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.60413508 |
44 | Spondylolisthesis (HP:0003302) | 2.56489890 |
45 | Cervical subluxation (HP:0003308) | 2.54984087 |
46 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.52387426 |
47 | Vertebral compression fractures (HP:0002953) | 2.51780331 |
48 | Myocardial infarction (HP:0001658) | 2.51701025 |
49 | Vascular calcification (HP:0004934) | 2.50085908 |
50 | Cone-rod dystrophy (HP:0000548) | 2.48045185 |
51 | Chronic obstructive pulmonary disease (HP:0006510) | 2.45030777 |
52 | Obstructive lung disease (HP:0006536) | 2.45030777 |
53 | Conjugated hyperbilirubinemia (HP:0002908) | 2.44710843 |
54 | Hyperlipoproteinemia (HP:0010980) | 2.43167520 |
55 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.42951691 |
56 | Joint hemorrhage (HP:0005261) | 2.38661763 |
57 | Nasal polyposis (HP:0100582) | 2.37712259 |
58 | Abnormality of the common coagulation pathway (HP:0010990) | 2.35968460 |
59 | Gingivitis (HP:0000230) | 2.34702353 |
60 | Cardiovascular calcification (HP:0011915) | 2.30224057 |
61 | Entropion (HP:0000621) | 2.30137493 |
62 | Hepatosplenomegaly (HP:0001433) | 2.27372818 |
63 | Abnormality of iron homeostasis (HP:0011031) | 2.24796463 |
64 | Hypoalphalipoproteinemia (HP:0003233) | 2.24073458 |
65 | Enlarged epiphyses (HP:0010580) | 2.23901404 |
66 | Decreased subcutaneous fat (HP:0001002) | 2.23736790 |
67 | Bone pain (HP:0002653) | 2.23496867 |
68 | Mitral stenosis (HP:0001718) | 2.23100380 |
69 | Abnormality of complement system (HP:0005339) | 2.22995204 |
70 | Increased mean platelet volume (HP:0011877) | 2.22775293 |
71 | Prolonged partial thromboplastin time (HP:0003645) | 2.22703322 |
72 | Abnormal platelet volume (HP:0011876) | 2.22015246 |
73 | Nephritis (HP:0000123) | 2.21739440 |
74 | Upper motor neuron abnormality (HP:0002127) | 2.20155262 |
75 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.19008368 |
76 | Pathologic fracture (HP:0002756) | 2.18979215 |
77 | Protuberant abdomen (HP:0001538) | 2.18767313 |
78 | * Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.17622597 |
79 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.17216149 |
80 | Hematochezia (HP:0002573) | 2.16300305 |
81 | Metaphyseal irregularity (HP:0003025) | 2.16251196 |
82 | Abnormality of the intrinsic pathway (HP:0010989) | 2.16237582 |
83 | Hemorrhage of the eye (HP:0011885) | 2.16014073 |
84 | Disinhibition (HP:0000734) | 2.15692239 |
85 | Tetany (HP:0001281) | 2.14504245 |
86 | Neurofibrillary tangles (HP:0002185) | 2.13008331 |
87 | Hypoglycemic coma (HP:0001325) | 2.12386713 |
88 | Increased CSF protein (HP:0002922) | 2.11909008 |
89 | Thick nail (HP:0001805) | 2.11387093 |
90 | Abnormal trabecular bone morphology (HP:0100671) | 2.10425974 |
91 | Abnormality of purine metabolism (HP:0004352) | 2.10253762 |
92 | Hyperglycinuria (HP:0003108) | 2.09537407 |
93 | Cerebral inclusion bodies (HP:0100314) | 2.09147977 |
94 | Bulbar palsy (HP:0001283) | 2.08076100 |
95 | Retinal atrophy (HP:0001105) | 2.05686463 |
96 | Fat malabsorption (HP:0002630) | 2.05356640 |
97 | Epidermoid cyst (HP:0200040) | 2.04763293 |
98 | Ketosis (HP:0001946) | 2.04184159 |
99 | Asymmetric septal hypertrophy (HP:0001670) | 2.03492165 |
100 | Conjunctival telangiectasia (HP:0000524) | 2.03280760 |
101 | Tetraparesis (HP:0002273) | 2.01585459 |
102 | Gingival bleeding (HP:0000225) | 2.01439611 |
103 | Erythroderma (HP:0001019) | 1.98857715 |
104 | Recurrent skin infections (HP:0001581) | 1.97816183 |
105 | Esophageal varix (HP:0002040) | 1.97740638 |
106 | Joint stiffness (HP:0001387) | 1.96706848 |
107 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.95620034 |
108 | Impaired platelet aggregation (HP:0003540) | 1.94076051 |
109 | Abnormal platelet function (HP:0011869) | 1.94076051 |
110 | Abnormality of glycine metabolism (HP:0010895) | 1.92179020 |
111 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.92179020 |
112 | Ragged-red muscle fibers (HP:0003200) | 1.90607688 |
113 | Thoracic kyphosis (HP:0002942) | 1.90363932 |
114 | Hepatocellular carcinoma (HP:0001402) | 1.88801005 |
115 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87193219 |
116 | Distal lower limb muscle weakness (HP:0009053) | 1.86876997 |
117 | Hypertriglyceridemia (HP:0002155) | 1.86739973 |
118 | Increased IgM level (HP:0003496) | 1.86657144 |
119 | Mutism (HP:0002300) | 1.86415334 |
120 | Amyloidosis (HP:0011034) | 1.84297533 |
121 | Steatorrhea (HP:0002570) | 1.83818964 |
122 | Peripheral demyelination (HP:0011096) | 1.83346964 |
123 | Death in childhood (HP:0003819) | 1.83137939 |
124 | Aortic aneurysm (HP:0004942) | 1.83120210 |
125 | Abnormality of the lumbar spine (HP:0100712) | 1.82807283 |
126 | Poikiloderma (HP:0001029) | 1.82329356 |
127 | Abnormality of methionine metabolism (HP:0010901) | 1.80375047 |
128 | Ketoacidosis (HP:0001993) | 1.79491781 |
129 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.79399095 |
130 | Hypoglycemic seizures (HP:0002173) | 1.79028334 |
131 | Colitis (HP:0002583) | 1.78439810 |
132 | Sensorimotor neuropathy (HP:0007141) | 1.77855147 |
133 | Autoimmune thrombocytopenia (HP:0001973) | 1.77349509 |
134 | Skin nodule (HP:0200036) | 1.77217898 |
135 | Distal upper limb amyotrophy (HP:0007149) | 1.77011129 |
136 | Upper limb amyotrophy (HP:0009129) | 1.77011129 |
137 | Mesangial abnormality (HP:0001966) | 1.75752450 |
138 | Coarse hair (HP:0002208) | 1.75415163 |
139 | Urticaria (HP:0001025) | 1.74382576 |
140 | Apathy (HP:0000741) | 1.73368941 |
141 | Diminished motivation (HP:0000745) | 1.73315996 |
142 | Abnormality of the thoracic spine (HP:0100711) | 1.72962524 |
143 | Menorrhagia (HP:0000132) | 1.72396879 |
144 | Ovoid vertebral bodies (HP:0003300) | 1.72120766 |
145 | Cardiomegaly (HP:0001640) | 1.71556262 |
146 | Abnormality of lateral ventricle (HP:0030047) | 1.70781047 |
147 | Rough bone trabeculation (HP:0100670) | 1.70507387 |
148 | Dementia (HP:0000726) | 1.69416278 |
149 | * Abnormality of fatty-acid metabolism (HP:0004359) | 1.69069172 |
150 | Hypercholesterolemia (HP:0003124) | 1.68283936 |
151 | Prominent metopic ridge (HP:0005487) | 1.68024029 |
152 | Polygenic inheritance (HP:0010982) | 1.63153488 |
153 | Zonular cataract (HP:0010920) | 1.62538799 |
154 | Hypertensive crisis (HP:0100735) | 1.60797061 |
155 | Thrombocytosis (HP:0001894) | 1.59103621 |
156 | Paralysis (HP:0003470) | 1.59032858 |
157 | Hand muscle atrophy (HP:0009130) | 1.59015066 |
158 | Neuronal loss in central nervous system (HP:0002529) | 1.58839306 |
159 | Widely patent fontanelles and sutures (HP:0004492) | 1.58638482 |
160 | Polycythemia (HP:0001901) | 1.58393366 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 5.38288439 |
2 | TESK1 | 3.41397219 |
3 | NME2 | 3.39617132 |
4 | INSRR | 3.29886024 |
5 | AKT3 | 3.22720639 |
6 | DDR2 | 3.18157251 |
7 | TAOK2 | 3.16762028 |
8 | TAOK3 | 2.88040269 |
9 | SIK1 | 2.70426281 |
10 | TGFBR2 | 2.63832553 |
11 | BCKDK | 2.51015025 |
12 | IRAK3 | 2.48771528 |
13 | TESK2 | 2.25330936 |
14 | MAP3K11 | 2.21703716 |
15 | PRKG2 | 2.20640498 |
16 | IRAK4 | 1.91655832 |
17 | IRAK2 | 1.90960588 |
18 | EPHB1 | 1.85996025 |
19 | BLK | 1.80972704 |
20 | TYK2 | 1.71865510 |
21 | TRPM7 | 1.67778401 |
22 | TAOK1 | 1.66040313 |
23 | TRIB3 | 1.63430596 |
24 | FRK | 1.59661554 |
25 | MAP3K1 | 1.59611991 |
26 | PTK6 | 1.53610342 |
27 | PDK2 | 1.47362421 |
28 | TBK1 | 1.46460197 |
29 | JAK1 | 1.45531217 |
30 | CSK | 1.41973135 |
31 | EPHA3 | 1.39935897 |
32 | CAMK1G | 1.39375403 |
33 | NUAK1 | 1.39248523 |
34 | ITK | 1.28660736 |
35 | MAP4K1 | 1.26615335 |
36 | MAP3K14 | 1.24801621 |
37 | ARAF | 1.23236934 |
38 | MAP2K2 | 1.23188297 |
39 | SMG1 | 1.23027685 |
40 | ABL2 | 1.22188144 |
41 | ICK | 1.21068730 |
42 | RIPK1 | 1.19932401 |
43 | FGFR4 | 1.18888867 |
44 | PRPF4B | 1.17991581 |
45 | MAP3K5 | 1.17967065 |
46 | CSF1R | 1.17451815 |
47 | PLK4 | 1.15616796 |
48 | MAP3K3 | 1.12332416 |
49 | CDC42BPA | 1.11314758 |
50 | PRKD3 | 1.09214477 |
51 | PRKD2 | 1.06529636 |
52 | TEC | 1.05394121 |
53 | KDR | 1.05208179 |
54 | SGK2 | 1.04990441 |
55 | SGK3 | 1.03414951 |
56 | JAK2 | 1.03335788 |
57 | CAMK1D | 1.03268187 |
58 | JAK3 | 1.03234326 |
59 | LATS1 | 1.02708958 |
60 | MST4 | 1.02509749 |
61 | PINK1 | 1.01741520 |
62 | BMPR1B | 0.99637128 |
63 | MAPK15 | 0.95707459 |
64 | BMX | 0.92740950 |
65 | MAP2K3 | 0.92061158 |
66 | RIPK4 | 0.91534692 |
67 | MAP3K8 | 0.91498068 |
68 | BTK | 0.91456135 |
69 | PTK2 | 0.91423944 |
70 | MOS | 0.91142973 |
71 | IKBKB | 0.89735794 |
72 | TTN | 0.87085386 |
73 | ZAP70 | 0.86130714 |
74 | MARK3 | 0.85657517 |
75 | STK38 | 0.84490699 |
76 | CDK12 | 0.81788920 |
77 | STK10 | 0.80726990 |
78 | PAK4 | 0.79717351 |
79 | DYRK1B | 0.78086550 |
80 | MAP2K6 | 0.77112161 |
81 | CHUK | 0.75949346 |
82 | BRAF | 0.75341651 |
83 | FGR | 0.75034146 |
84 | MAP3K2 | 0.74674447 |
85 | PDGFRA | 0.73636764 |
86 | SCYL2 | 0.72037052 |
87 | LIMK1 | 0.70119845 |
88 | SGK494 | 0.68547277 |
89 | SGK223 | 0.68547277 |
90 | PRKCH | 0.68290853 |
91 | GRK6 | 0.67725846 |
92 | MAP3K13 | 0.67695817 |
93 | MET | 0.67636499 |
94 | PAK1 | 0.65963204 |
95 | GRK7 | 0.64160748 |
96 | RPS6KC1 | 0.64000039 |
97 | RPS6KL1 | 0.64000039 |
98 | MAPK12 | 0.63655280 |
99 | PIK3CG | 0.61277452 |
100 | NEK6 | 0.60749791 |
101 | STK38L | 0.59294445 |
102 | OXSR1 | 0.58190531 |
103 | STK3 | 0.57717406 |
104 | IRAK1 | 0.57340883 |
105 | IKBKE | 0.57241524 |
106 | MARK2 | 0.55043615 |
107 | RPS6KA2 | 0.54219237 |
108 | PDPK1 | 0.53332536 |
109 | SYK | 0.52975294 |
110 | KIT | 0.52380023 |
111 | MAPKAPK3 | 0.52245330 |
112 | PDGFRB | 0.51968659 |
113 | YES1 | 0.51871714 |
114 | BMPR2 | 0.51611900 |
115 | KSR2 | 0.51147527 |
116 | MAPK11 | 0.49751421 |
117 | CDK9 | 0.49744445 |
118 | HCK | 0.49502612 |
119 | LMTK2 | 0.48563613 |
120 | BRD4 | 0.48180482 |
121 | IGF1R | 0.48146154 |
122 | MYLK | 0.47939023 |
123 | NEK9 | 0.47788682 |
124 | TIE1 | 0.47370956 |
125 | FGFR1 | 0.47155328 |
126 | MAPK7 | 0.47060409 |
127 | LYN | 0.46736485 |
128 | MTOR | 0.46509624 |
129 | TLK1 | 0.46065865 |
130 | PIM2 | 0.45623637 |
131 | MAPKAPK2 | 0.44172369 |
132 | RPS6KA6 | 0.43837216 |
133 | TYRO3 | 0.41758275 |
134 | FLT3 | 0.40710925 |
135 | EEF2K | 0.40661970 |
136 | MST1R | 0.39755025 |
137 | PAK2 | 0.37801833 |
138 | PTK2B | 0.36529665 |
139 | MATK | 0.35296693 |
140 | CDK7 | 0.34425648 |
141 | STK16 | 0.33945122 |
142 | INSR | 0.33910854 |
143 | PRKD1 | 0.33583146 |
144 | EGFR | 0.32750790 |
145 | TNK2 | 0.31339246 |
146 | PDK1 | 0.30436450 |
147 | LCK | 0.30059540 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.00916881 |
2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.86617473 |
3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.75763081 |
4 | * Lysosome_Homo sapiens_hsa04142 | 2.75607682 |
5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.17673839 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.07152771 |
7 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.96877519 |
8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.89730388 |
9 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.88836635 |
10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.85042463 |
11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.84001621 |
12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.77473131 |
13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.68135990 |
14 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.64568115 |
15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.64553924 |
16 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.64299502 |
17 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.62493636 |
18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.53468423 |
19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.46302318 |
20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.42581671 |
21 | ABC transporters_Homo sapiens_hsa02010 | 1.38118424 |
22 | Sulfur relay system_Homo sapiens_hsa04122 | 1.36048956 |
23 | Peroxisome_Homo sapiens_hsa04146 | 1.33769044 |
24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29244952 |
25 | Platelet activation_Homo sapiens_hsa04611 | 1.25683708 |
26 | Phagosome_Homo sapiens_hsa04145 | 1.24698494 |
27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24025470 |
28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23877135 |
29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.23382155 |
30 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.22176483 |
31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.22107049 |
32 | Leishmaniasis_Homo sapiens_hsa05140 | 1.19764899 |
33 | Salmonella infection_Homo sapiens_hsa05132 | 1.19155643 |
34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19065742 |
35 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.15521076 |
36 | Endocytosis_Homo sapiens_hsa04144 | 1.13962107 |
37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.13513149 |
38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13494572 |
39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.12867266 |
40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.12381078 |
41 | Shigellosis_Homo sapiens_hsa05131 | 1.11523026 |
42 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.11457913 |
43 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.11341245 |
44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.10682881 |
45 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.10559518 |
46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.10349212 |
47 | Allograft rejection_Homo sapiens_hsa05330 | 1.06075894 |
48 | Malaria_Homo sapiens_hsa05144 | 1.05179434 |
49 | Legionellosis_Homo sapiens_hsa05134 | 1.04618997 |
50 | Lysine degradation_Homo sapiens_hsa00310 | 1.00551199 |
51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.99229414 |
52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.99136955 |
53 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.97961475 |
54 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.97806279 |
55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97796380 |
56 | Retinol metabolism_Homo sapiens_hsa00830 | 0.96981929 |
57 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.96867553 |
58 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.96826919 |
59 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.94165413 |
60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92972904 |
61 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.92657066 |
62 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.92511443 |
63 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.91352909 |
64 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.90571914 |
65 | Protein export_Homo sapiens_hsa03060 | 0.90362307 |
66 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.89343372 |
67 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.88221253 |
68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.87612075 |
69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.86677486 |
70 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.86075020 |
71 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.85762608 |
72 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.85758901 |
73 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.85456564 |
74 | Measles_Homo sapiens_hsa05162 | 0.85040496 |
75 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84674088 |
76 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.83914817 |
77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.82523083 |
78 | Tuberculosis_Homo sapiens_hsa05152 | 0.81415075 |
79 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.81306413 |
80 | Insulin resistance_Homo sapiens_hsa04931 | 0.80765670 |
81 | Pertussis_Homo sapiens_hsa05133 | 0.79439344 |
82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78856345 |
83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.78162250 |
84 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.75024005 |
85 | Hepatitis C_Homo sapiens_hsa05160 | 0.74924970 |
86 | Bile secretion_Homo sapiens_hsa04976 | 0.74467490 |
87 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.74385379 |
88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73839920 |
89 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.73425887 |
90 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.73385756 |
91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.72714548 |
92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72672765 |
93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72635560 |
94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72066691 |
95 | Hepatitis B_Homo sapiens_hsa05161 | 0.70749497 |
96 | Prion diseases_Homo sapiens_hsa05020 | 0.70720438 |
97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.70068699 |
98 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69962741 |
99 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.69822771 |
100 | Amoebiasis_Homo sapiens_hsa05146 | 0.69715404 |
101 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.69605790 |
102 | Asthma_Homo sapiens_hsa05310 | 0.68172067 |
103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66996291 |
104 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66762361 |
105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65509532 |
106 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65178862 |
107 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64639773 |
108 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.62605646 |
109 | Apoptosis_Homo sapiens_hsa04210 | 0.62066665 |
110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60137878 |
111 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59556523 |
112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59484090 |
113 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58806123 |
114 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58028554 |
115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57962475 |
116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57305683 |
117 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.56785560 |
118 | Influenza A_Homo sapiens_hsa05164 | 0.55954387 |
119 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.55847916 |
120 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.55244694 |
121 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54407123 |
122 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.53999923 |
123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52940900 |
124 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52860497 |
125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52502296 |
126 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52003792 |
127 | Prostate cancer_Homo sapiens_hsa05215 | 0.51072029 |
128 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49845011 |
129 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49827557 |
130 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.49351092 |
131 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.48880856 |
132 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48804084 |
133 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48567887 |
134 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48151244 |
135 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47846038 |
136 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47446348 |
137 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.47417398 |
138 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46163039 |
139 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.45062011 |
140 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.43773773 |
141 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.42367835 |
142 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41964762 |
143 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41845805 |
144 | Bladder cancer_Homo sapiens_hsa05219 | 0.41492599 |
145 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41470393 |
146 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.41019999 |
147 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40992193 |
148 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.40390380 |
149 | Focal adhesion_Homo sapiens_hsa04510 | 0.39142146 |
150 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38875768 |
151 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35530100 |